News and Analysis

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for

Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from

Sen. Bill Cassidy (R-La.) on Sunday expressed cautious optimism about a bipartisan compromise on extending enhanced Affordable Care Act (ACA) subsidies for a select group

Using Section 232 national-security tariffs on imported medical equipment risks repeating the same mistakes that have long plagued U.S. health policy: relying on blunt instruments